Researchers find social pressure, not free drug paraphernalia, helps with recovery
How the Biden Admin's Refusal to Cover New Alzheimer's Drugs Hurts 'Underserved' Americans and Costs Taxpayers Billions
'The tragedy of Alzheimer's disease is exacerbated by inaction of policymakers,' University of Chicago prof says
Supply chain snafu threatens to derail Biden's pledge to 'end cancer as we know it'
Firearm purchase is at the center of a Justice Department investigation into the troubled first son